Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
09/2000
09/14/2000WO2000053605A1 Tyrosine kinase inhibitors
09/14/2000WO2000053602A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053600A1 Novel piperidine derivatives
09/14/2000WO2000053595A1 Pyrimidine compounds
09/14/2000WO2000053581A2 Heterocyclic compounds having antitumor activity
09/14/2000WO2000053563A1 Novel ligands of nuclear receptors ppar's
09/14/2000WO2000053562A1 Retinoid antagonists and use thereof
09/14/2000WO2000053236A2 Methods and compositions for targeted drug delivery
09/14/2000WO2000053232A1 Matriptase, a serine protease and its applications
09/14/2000WO2000053231A2 Fatty acid-anticancer conjugates and uses thereof
09/14/2000WO2000053227A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053198A1 Inhibitor of lipoxygenase pathways
09/14/2000WO2000053196A1 Matrix protein compositions for induction of apoptosis
09/14/2000WO2000053194A1 Remedies for joint diseases
09/14/2000WO2000053185A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053178A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000WO2000053169A2 Method of inhibiting a chaperone protein
09/14/2000WO2000053157A1 Improved powdery pharmaceutical compositions for inhalation
09/14/2000WO2000037504A3 Human monoclonal antibodies to ctla-4
09/14/2000WO2000037422A3 Ion channel modulating agents
09/14/2000WO2000037065A3 Endocrine therapy for breast cancer: combined treatment with tamoxifen plus alkyl pcdfs
09/14/2000WO2000035469A3 hCG THERAPY FOR THE TREATMENT OF BREAST CANCER
09/14/2000WO2000035430A3 Homer a new target of treating psychiatric disorders
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration
09/14/2000WO2000030587A3 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES
09/14/2000WO2000027883B1 A method of treating tumors using fas-induced apoptosis
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000WO2000024913A3 Mn gene and protein
09/14/2000WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation
09/14/2000WO2000018439A3 Use of neoangiogenesis markers for diagnosing and treating tumours by therapy
09/14/2000WO1999065228A3 Pharmaceutical combination used to compensate for a testosterone deficiency while protecting the prostate
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000CA2367334A1 Compositions and methods for the treatment of tumors
09/14/2000CA2367315A1 Apoptosis inducing molecule ii and methods of use
09/14/2000CA2367144A1 Agents to increase the uptake of pharmaceuticals and diagnostic substances into solid tumors
09/14/2000CA2367130A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367113A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2367108A1 Method of inhibiting a chaperone protein
09/14/2000CA2366675A1 L-arabino-disaccharides of anthracyclines, processes for their preparation, and pharmaceutical compositions containing them
09/14/2000CA2366668A1 Pyrimidine compounds
09/14/2000CA2366644A1 Tyrosine kinase inhibitors
09/14/2000CA2366615A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone
09/14/2000CA2366602A1 Pyridoxal analogues for vitamin b-6 disorders
09/14/2000CA2366281A1 Novel ligands of nuclear receptors ppar's
09/14/2000CA2366147A1 Casb618 polynucleotides and polypeptides and their use
09/14/2000CA2366087A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000CA2365354A1 Methods and compositions for targeted drug delivery
09/14/2000CA2365230A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000CA2363255A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
09/14/2000CA2362885A1 Human kallikrein-like genes
09/14/2000CA2362670A1 Matriptase, a serine protease and its applications
09/14/2000CA2362422A1 Polynucleotides and proteins encoded thereby
09/14/2000CA2362370A1 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/13/2000EP1034795A2 Conjugates of lipids and biologically active compounds
09/13/2000EP1034301A1 Inhibition of an fgf-binding protein using ribozymes
09/13/2000EP1034299A1 Method for suppressing multiple drug resistance in cancer cells
09/13/2000EP1034288A1 Methods of isolating and using cd7+cd34-lin-hematopoietic cells
09/13/2000EP1034265A1 Human cdc10 homolog
09/13/2000EP1034207A1 BIODEGRADABLE LOW MOLECULAR WEIGHT TRIBLOCK POLY(LACTIDE-co-GLYCOLIDE) POLYETHYLENE GLYCOL COPOLYMERS HAVING REVERSE THERMAL GELATION PROPERTIES
09/13/2000EP1034185A2 Pharmaceutical compositions containing the long pentraxin ptx3
09/13/2000EP1034000A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection
09/13/2000EP1033981A1 Formulations and methods for reducing toxicity of antineoplastic agents
09/13/2000EP1033979A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
09/13/2000EP1033972A1 Drug delivery system with two-step targeting
09/13/2000EP1033971A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
09/13/2000EP0983248A4 Analogs of duocarmycin and cc-1065
09/13/2000EP0764166B1 Corticotropin releasing factor antagonists
09/13/2000EP0691962B1 1-amino-3-phenoxy propane derivatives as modulators of multi-drug resistance
09/13/2000EP0683664B1 Taxol formulation
09/13/2000EP0674652B1 Dolastatin analog
09/13/2000CN1266459A Method and reagents for vaccination which generate a CD8 T cell immune response
09/13/2000CN1266435A Process for preparing and purifying 9-nitro-20-camptothecin
09/13/2000CN1266433A Benzpyrido cycloheptane compounds useful for inhibition of franesyl protein transferase
09/13/2000CN1266432A Bispyrido-cyclohepatne compounds useful for inhibition of farnesyl protein transferase
09/13/2000CN1266421A Anti-cancer compounds
09/13/2000CN1265901A Traditional Chinese medicinal pill for anti-cancer
09/13/2000CN1056381C Active peptide for promoting immunization function and usage thereof
09/13/2000CN1056378C Intermediate for preparing etoposide glucoside and its preparation process
09/13/2000CN1056300C Oral traditional Chinese medicine composition for treating gastric cancer
09/12/2000US6118011 Mixture of lipid and taxane
09/12/2000US6118001 Anticancer agent; antiarthritic agent
09/12/2000US6117991 Plasmid pav2-htsh-beta on deposit as atcc 75505; for recombinant production, diagnosis and therapy of human thyroid cancer; anticarcinogenic agents
09/12/2000US6117989 Human calcium-binding proteins
09/12/2000US6117902 6,8-dimercaptooctanoic acid derivatives substituted at the 6-S and/or 8-S position with the (3-methylthiopropanoyl) radical and pharmaceutical compositions intended for the treatment of cancerous tumors
09/12/2000US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase
09/12/2000US6117848 Antisense oligonucleotide inhibition of ras
09/12/2000US6117421 Method for promoting cell growth and immunosuppression using chaperonin
09/08/2000WO2000052210A2 Methods for targeting rna molecules
09/08/2000WO2000052205A2 cDNA FOR HUMAN METHYLENETETRAHYDROFOLATE REDUCTASE
09/08/2000WO2000052184A1 Anti-neoplastic compositions and uses thereof
09/08/2000WO2000052165A2 Compositions and methods for breast cancer therapy and diagnosis
09/08/2000WO2000052158A1 Methods and reagents for inhibiting angiogenesis
09/08/2000WO2000052157A1 Tumor-associated antigen
09/08/2000WO2000052156A1 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene
09/08/2000WO2000052134A2 Inhibitors of prenyl-protein transferase
09/08/2000WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
1 ... 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 ... 2211